探讨联合应用吸入一氧化氮(INO)和肺表面活性物质(PS)对实验性急性呼吸窘迫综合征(ARDS)的治疗作用。
URPOSE to assess the efficacy of a combined inhaled nitric oxide (INO) and intratracheal exogenous pulmonary surfactant (PS) therapy in experimental acute respiratory distress syndrome (ARDS).
结论肺表面活性物质治疗肺透明膜病，可以迅速纠正患者的血气指标异常，值得临床推广应用。
Conclusion Pulmonary surfactant therapy in hyaline membrane disease of newborns can quickly correct the abnormal blood gas, and hence is worthy of being recommended in clinical practice.
这样的组合物及方法应用蛋白酶抑制剂和一种肺表面活性物质 混合物。
Such compositions and methods employ protease inhibitors and a lung surfactant mixture.
应用推荐